Pharmaceutical Executive-05-01-2012

Issue PDF
Pharmaceutical Executive

May 01, 2012

Marooned at the Top

Pharmaceutical Executive
From the Editor

May 01, 2012

The industry's reputation as a growth industry no one wants to pay for is more secure than ever, writes Pharm Exec Editor William Looney.

Pharmaceutical Executive

Will changes to the P&R system in the UK finally put some real metrics behind the elusive concept of value?

Pharmaceutical Executive

More consolidation didn't boost sales at the top, but a handful of nimble newcomers posted impressive growth on the other end of the curve.

Pharmaceutical Executive
Country Report

May 01, 2012

In just the past few years, South Africa has hit several key economic benchmarks demonstrating the country's upward trajectory.

Pharmaceutical Executive
Special Section

May 01, 2012

Companies know they need regulatory information management. What they don't always know is where to start and how to weave this vital capability across the enterprise.

Pharmaceutical Executive

Options for using data have proliferated to the point of becoming overwhelming. So what opportunities does this information explosion present?

Pharmaceutical Executive
Column

May 01, 2012

In late March, the Supreme Court debated the merits-or lack thereof-of the Obama Administration's Patient Protection and Affordable Care Act. Can you match the analogy with the Justice?

Column
Pharmaceutical Executive

May 01, 2012

To gain market access in emerging markets, pharma companies face pressure to offer a convincing Corporate Value Proposition to governments.

Special Section
Pharmaceutical Executive

May 01, 2012

Data has become as important as the drug in driving success in healthcare.

Pharmaceutical Executive
Special Section

May 01, 2012

Highlighting the companies awarded for exemplifying a high level of operational excellence with technology.